BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 14508031)

  • 21. Cortical gamma-aminobutyric acid levels across the menstrual cycle in healthy women and those with premenstrual dysphoric disorder: a proton magnetic resonance spectroscopy study.
    Epperson CN; Haga K; Mason GF; Sellers E; Gueorguieva R; Zhang W; Weiss E; Rothman DL; Krystal JH
    Arch Gen Psychiatry; 2002 Sep; 59(9):851-8. PubMed ID: 12215085
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reduced phase-advance of plasma melatonin after bright morning light in the luteal, but not follicular, menstrual cycle phase in premenstrual dysphoric disorder: an extended study.
    Parry BL; Meliska CJ; Sorenson DL; Martínez LF; López AM; Elliott JA; Hauger RL
    Chronobiol Int; 2011 May; 28(5):415-24. PubMed ID: 21721857
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Insomnia, Inattention and Fatigue Symptoms of Women with Premenstrual Dysphoric Disorder.
    Lin PC; Ko CH; Lin YJ; Yen JY
    Int J Environ Res Public Health; 2021 Jun; 18(12):. PubMed ID: 34201084
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cortisol circadian rhythms during the menstrual cycle and with sleep deprivation in premenstrual dysphoric disorder and normal control subjects.
    Parry BL; Javeed S; Laughlin GA; Hauger R; Clopton P
    Biol Psychiatry; 2000 Nov; 48(9):920-31. PubMed ID: 11074230
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Premenstrual dysphoric disorder and prefrontal reactivity during anticipation of emotional stimuli.
    Gingnell M; Bannbers E; Wikström J; Fredrikson M; Sundström-Poromaa I
    Eur Neuropsychopharmacol; 2013 Nov; 23(11):1474-83. PubMed ID: 24001875
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Brain activation during emotion regulation in women with premenstrual dysphoric disorder.
    Petersen N; Ghahremani DG; Rapkin AJ; Berman SM; Liang L; London ED
    Psychol Med; 2018 Aug; 48(11):1795-1802. PubMed ID: 29145910
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevalence and predictors of premenstrual dysphoric disorder (PMDD) in older premenopausal women. The Harvard Study of Moods and Cycles.
    Cohen LS; Soares CN; Otto MW; Sweeney BH; Liberman RF; Harlow BL
    J Affect Disord; 2002 Jul; 70(2):125-32. PubMed ID: 12117624
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevalence and correlates of current suicidal ideation in women with premenstrual dysphoric disorder.
    Wikman A; Sacher J; Bixo M; Hirschberg AL; Kopp Kallner H; Epperson CN; Comasco E; Sundström Poromaa I
    BMC Womens Health; 2022 Feb; 22(1):35. PubMed ID: 35148753
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adrenergic receptors in premenstrual dysphoric disorder. II. Neutrophil beta2-adrenergic receptors: Gs protein coupling, phase of menstrual cycle and prediction of luteal phase symptom severity.
    Gurguis GN; Yonkers KA; Blakeley JE; Phan SP; Williams A; Rush AJ
    Psychiatry Res; 1998 Jun; 79(1):31-42. PubMed ID: 9676824
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Patients with premenstrual dysphoric disorder have increased startle modulation during anticipation in the late luteal phase period in comparison to control subjects.
    Bannbers E; Kask K; Wikström J; Risbrough V; Poromaa IS
    Psychoneuroendocrinology; 2011 Sep; 36(8):1184-92. PubMed ID: 21435793
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevalence, correlates, comorbidities, and suicidal tendencies of premenstrual dysphoric disorder in a nationwide sample of Korean women.
    Hong JP; Park S; Wang HR; Chang SM; Sohn JH; Jeon HJ; Lee HW; Cho SJ; Kim BS; Bae JN; Cho MJ
    Soc Psychiatry Psychiatr Epidemiol; 2012 Dec; 47(12):1937-45. PubMed ID: 22538387
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adrenergic receptors in premenstrual dysphoric disorder: I. Platelet alpha 2 receptors: Gi protein coupling, phase of menstrual cycle, and prediction of luteal phase symptom severity.
    Gurguis GN; Yonkers KA; Phan SP; Blakeley JE; Williams A; Rush AJ
    Biol Psychiatry; 1998 Oct; 44(7):600-9. PubMed ID: 9787884
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Estrogen, progesterone, cortisol, brain-derived neurotrophic factor, and vascular endothelial growth factor during the luteal phase of the menstrual cycle in women with premenstrual dysphoric disorder.
    Ko CH; Wong TH; Suen JL; Lin PC; Long CY; Yen JY
    J Psychiatr Res; 2024 Jan; 169():307-317. PubMed ID: 38070471
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Premenstrual symptoms and luteal suicide attempts.
    Baca-Garcia E; Diaz-Sastre C; Ceverino A; García Resa E; Oquendo MA; Saiz-Ruiz J; de Leon J
    Eur Arch Psychiatry Clin Neurosci; 2004 Oct; 254(5):326-9. PubMed ID: 15365708
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serum brain-derived neurotrophic factor differences between the luteal and follicular phases in premenstrual dysphoric disorder.
    Oral E; Kirkan TS; Yildirim A; Kotan Z; Cansever Z; Ozcan H; Aliyev E; Gulec M
    Gen Hosp Psychiatry; 2015; 37(3):266-72. PubMed ID: 25799087
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The association between premenstrual dysphoric disorder and internet use disorder.
    Ko CH; Yen CF; Long CY; Chen CS; Huang TH; Yen JY
    Women Health; 2014; 54(3):245-61. PubMed ID: 24512539
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sensitivity to CCK-4 in women with and without premenstrual dysphoric disorder (PMDD) during their follicular and luteal phases.
    Le Mellédo JM; Merani S; Koszycki D; Bellavance F; Palmour R; Gutkowska J; Steinberg S; Bichet DG; Bradwejn J
    Neuropsychopharmacology; 1999 Jan; 20(1):81-91. PubMed ID: 9885787
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differences in free estradiol and sex hormone-binding globulin in women with and without premenstrual dysphoric disorder.
    Thys-Jacobs S; McMahon D; Bilezikian JP
    J Clin Endocrinol Metab; 2008 Jan; 93(1):96-102. PubMed ID: 17956950
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Proton magnetic resonance spectroscopy measurement of brain glutamate levels in premenstrual dysphoric disorder.
    Batra NA; Seres-Mailo J; Hanstock C; Seres P; Khudabux J; Bellavance F; Baker G; Allen P; Tibbo P; Hui E; Le Melledo JM
    Biol Psychiatry; 2008 Jun; 63(12):1178-84. PubMed ID: 18061146
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nocturnal polysomnographic sleep across the menstrual cycle in premenstrual dysphoric disorder.
    Shechter A; Lespérance P; Ng Ying Kin NM; Boivin DB
    Sleep Med; 2012 Sep; 13(8):1071-8. PubMed ID: 22749440
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.